Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 14/20 | 0.80 |
| ▸ | MMP2 | P08253 | 12/20 | 0.80 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6584898 | 0.90 | MMP2 (0.65) | MMP3MMP2SLC2A1EGLN1L3MBTL1 | |
| SCHEMBL6589722 | 0.89 | MMP3 (0.81) | MMP3MMP2L3MBTL1 | |
| SCHEMBL6586215 | 0.89 | MMP3 (1.00) | MMP3MMP2L3MBTL1 | |
| SCHEMBL6588213 | 0.84 | MMP3 (0.76) | MMP3MMP2EGLN1L3MBTL1 | |
| SCHEMBL6584456 | 0.84 | MMP3 (1.00) | MMP3MMP2EGLN1L3MBTL1 | |
| SCHEMBL6585982 | 0.84 | MMP3 (0.86) | MMP3MMP2EGLN1L3MBTL1 | |
| SCHEMBL6586903 | 0.83 | MMP3 (1.00) | MMP3MMP2L3MBTL1 | |
| SCHEMBL6585987 | 0.83 | MMP3 (0.81) | MMP3MMP2L3MBTL1 | |
| SCHEMBL6586818 | 0.83 | MMP3 (0.80) | MMP3MMP2EGLN1L3MBTL1 | |
| SCHEMBL6587727 | 0.82 | MMP3 (0.76) | MMP3MMP2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |